Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC8 | Q9BY41 | 3/20 | 0.43 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.43 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.43 |
| ▸ | ACHE | P22303 | 3/20 | 0.40 |
| ▸ | KIF11 | P52732 | 1/20 | 0.38 |
| ▸ | RXRA | P19793 | 2/20 | 0.38 |
| ▸ | RXRB | P28702 | 2/20 | 0.38 |
| ▸ | SOD1 | P00441 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.35 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.35 |
| ▸ | CASP3 | P42574 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.35 |
| ▸ | RELA | Q04206 | 1/20 | 0.35 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.35 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.35 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL34924 | 0.94 | ESR1 (0.36) | HDAC8HDAC4HDAC2ACHERXRA | |
| Carbimide SCHEMBL4253887 | 0.89 | ESR1 (0.33) | HDAC8HDAC4HDAC2CYP3A4ESR1 | |
| SCHEMBL12050426 | 0.89 | ESR1 (0.33) | HDAC8HDAC4HDAC2CYP3A4ESR1 | |
| SCHEMBL2494913 | 0.89 | ESR1 (0.33) | HDAC8HDAC4HDAC2CYP3A4ESR1 | |
| SCHEMBL24833769 | 0.87 | PGK1 (0.32) | HDAC8HDAC4HDAC2CYP3A4ESR1 | |
| SCHEMBL11535151 | 0.85 | CES2 (0.42) | GAA | |
| SCHEMBL14473846 | 0.85 | ESR1 (0.32) | HDAC8HDAC4HDAC2CYP2C19ESR1 | |
| SCHEMBL18126139 | 0.85 | ESR1 (0.32) | HDAC8HDAC4HDAC2ESR1ESR2 | |
| SCHEMBL13703565 | 0.85 | ESR1 (0.32) | HDAC8HDAC4HDAC2ESR1ESR2 | |
| SCHEMBL10018065 | 0.84 | HDAC8 (0.41) | HDAC8HDAC4HDAC2ACHEKIF11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3310165-B1 | PESTICIDAL MICROCAPSULES WITH A SHELL MADE OF TETRAMETHYLXYLYLENE DIISOCYANATE, CYCLOALIPHATIC DIISOCYANATE, AND ALIPHATIC DIAMINE | BASF SE (DE) | 2019-09-11 | — | — | EP | disclosed |
| US-20190151648-A1 | BIO-ELECTRODE COMPOSITION, BIO-ELECTRODE, AND METHOD FOR MANUFACTURING BIO-ELECTRODE | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2019-05-23 | — | — | US | disclosed |
| US-20180171058-A1 | Method for the Synthesis of Polymer Carbodiimides with Added Cesium Salts, Polymer Carbodiimides, and Use Thereof | LANXESS DEUTSCHLAND GMBH (DE) | 2018-06-21 | — | — | US | disclosed |
| WO-2018104117-A1 | CINMETHYLIN MICROCAPSULES WITH A SHELL MADE OF TETRAMETHYLXYLYLENE DIISOCYANATE AND A POLYAM-INE WITH AT LEAST THREE AMINE GROUPS | BASF Agro B.V. (NL) | 2018-06-14 | — | — | WO | disclosed |
| WO-2018104118-A1 | COMPOSITION COMPRISING POLYURETHANE MICROCAPSULES COMPRISING CINMETHYLIN | BASF Agro B.V. (NL) | 2018-06-14 | — | — | WO | disclosed |
| US-9287563-B2 | Electrode for lithium secondary battery and lithium secondary battery including the same | SAMSUNG SDI CO., LTD. (KR) | 2016-03-15 | — | — | US | disclosed |
| US-8802318-B2 | Compound and composition including compound, with fuel cell, fuel cell electrode and fuel cell electrolyte membrane using same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2014-08-12 | — | — | US | disclosed |
| US-20120189915-A1 | ELECTRODE FOR LITHIUM SECONDARY BATTERY AND LITHIUM SECONDARY BATTERY INCLUDING THE SAME | SAMSUNG SDI CO., LTD. (KR) | 2012-07-26 | — | — | US | disclosed |
| US-20110281200-A1 | COMPOUND AND COMPOSITION INCLUDING COMPOUND, WITH FUEL CELL, FUEL CELL ELECTRODE AND FUEL CELL ELECTROLYTE MEMBRANE USING SAME | SNU R&DB FOUNDATION (KR) | 2011-11-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190151648-A1 | BIO-ELECTRODE COMPOSITION, BIO-ELECTRODE, AND METHOD FOR MANUFACTURING BIO-ELECTRODE | FUCA1, GJA1, ASIC1 | HDAC8 2473/4885HDAC4 3820/4885HDAC2 2764/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.